- Home
- MAIA vs CKPT Comparison
MAIA vs CKPT Comparison
Compare MAIA & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- CKPT
- Stock Information
- Founded
- MAIA 2018
- CKPT 2014
- Country
- MAIA United States
- CKPT United States
- Employees
- MAIA N/A
- CKPT N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- CKPT Biotechnology: Pharmaceutical Preparations
- Sector
- MAIA Health Care
- CKPT Health Care
- Exchange
- MAIA Nasdaq
- CKPT Nasdaq
- Market Cap
- MAIA 62.4M
- CKPT N/A
- IPO Year
- MAIA 2022
- CKPT 2017
- Fundamental
- Price
- MAIA $2.82
- CKPT $3.77
- Analyst Decision
- MAIA
- CKPT Strong Buy
- Analyst Count
- MAIA 0
- CKPT 2
- Target Price
- MAIA N/A
- CKPT $12.00
- AVG Volume (30 Days)
- MAIA 60.0K
- CKPT 946.5K
- Earning Date
- MAIA 11-05-2024
- CKPT 11-11-2024
- Dividend Yield
- MAIA N/A
- CKPT N/A
- EPS Growth
- MAIA N/A
- CKPT N/A
- EPS
- MAIA N/A
- CKPT N/A
- Revenue
- MAIA N/A
- CKPT $78,000.00
- Revenue This Year
- MAIA N/A
- CKPT N/A
- Revenue Next Year
- MAIA N/A
- CKPT $151,162.55
- P/E Ratio
- MAIA N/A
- CKPT N/A
- Revenue Growth
- MAIA N/A
- CKPT N/A
- 52 Week Low
- MAIA $0.82
- CKPT $1.36
- 52 Week High
- MAIA $5.99
- CKPT $3.95
- Technical
- Relative Strength Index (RSI)
- MAIA 50.98
- CKPT 84.67
- Support Level
- MAIA $2.36
- CKPT $2.37
- Resistance Level
- MAIA $2.72
- CKPT $2.54
- Average True Range (ATR)
- MAIA 0.22
- CKPT 0.27
- MACD
- MAIA 0.02
- CKPT 0.10
- Stochastic Oscillator
- MAIA 72.28
- CKPT 88.60
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.